Webinar on Uncovering Mechanisms of Hepatotoxicity for High Affinity Antisense Oligonucleotides – 3’ end RNA-Seq Profilling Using GeneSpring GX


By Sebastien A. Burel, PhD, Director, Nonclinical Development, Ionis Pharmaceuticals, California
On 14 June 2017, 8 AM PST

Registration form